BRD4 and viral infectious disease: Interestingly, inhibition of BRD4 with JQ1 results in impaired proliferation of Tax-positive HTLV-1-infected cells, and then, in reduced Tax-mediated cell transformation and tumorigenesis [170], suggesting that BET inhibitors could also be used as anti-cancer therapy in tumors caused by viral infections.